CELL BIOTECH CO ., LTD Logo

CELL BIOTECH CO ., LTD

A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.

049960 | KO

Overview

Corporate Details

ISIN(s):
KR7049960008
LEI:
Country:
South Korea
Address:
경기 김포시 월곶면 개곡리 134, 김포시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cell Biotech Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and marketing of innovative probiotic solutions. Leveraging over 30 years of experience and proprietary fermentation and coating technologies, the company produces high-quality lactic acid bacteria (LAB) and GRAS-safe strains. Its core business includes producing probiotic raw materials, marketed as LAB2PRO; offering comprehensive OEM/ODM services for finished products tailored to global clients; and managing its own consumer brand, DUOLAC, which is exported to approximately 40 countries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-07-25 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 893.4 KB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.3 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-19 00:00
Audit Report / Information
[첨부추가]사업보고서 (2024.12)
Korean 438.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 112.4 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 107.7 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 108.1 KB

Automate Your Workflow. Get a real-time feed of all CELL BIOTECH CO ., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CELL BIOTECH CO ., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CELL BIOTECH CO ., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.